Vaccine Development and Production Challenges Manufacturers
19 March 2015
Vaccines are front-page news these days. Researchers are advancing new vaccines for Ebola and other devastating diseases, while manufacturers work with FDA to bring to market new products to combat dangerous infections and strategies to improve supplies of seasonal influenza shots.
Biopharmaceutical Sector Leads the Way in Clinical Trial Data Sharing
18 March 2015
Effective and responsible sharing of clinical trial data continues to expand scientific discourse and discovery, as we have chronicled here on the Catalyst.
U.K. looks to FDA 'breakthrough' status for inspiration in regulatory revamp
18 March 2015
The United Kingdom government has established the scope of the hotly anticipated review into the development and reimbursement of drugs. And the independent panel is being tasked with looking beyond the U.K.'s borders for inspiration, with an analysis of what can be learnt from FDA's "breakthrough" designation on its to-do list.
Google adds Tute database to burgeoning Genomics platform
18 March 2015
Google ($GOOG) has added another publicly available database to its growing Genomics platform. The latest deal sees Google Genomics host Tute Genomics' repository of 8.5 billion annotations of genetic variants, giving users another resource to probe with the tech giant's growing arsenal of data integration tools.
Survey: Lack of device connectivity leads to medical errors and $30B+ annual cost
17 March 2015
The transcription of medical data from devices by nurses is a common source of medical errors that costs the U.S. healthcare system upward of $30 billion. That's according to a survey and other data assembled by a nonprofit medical research organization, the West Health Institute.
From Ancestry to Health to Drug Development
17 March 2015
Consumer genetics firm 23andMe is getting in on the drug development business with the help of former Genentech executive Richard Scheller, as GenomeWeb has reported.
The Five Essential Truths about Prescription Drug Spending
17 March 2015
Every day patients around the world are living healthier, more productive lives thanks to innovative medicines developed by biopharmaceutical companies. Retail prescription medicines have consistently accounted for just 10 percent of United States health care spending and federal actuaries project this share will remain stable through the next decade.
Biotech in China is built brick-by-brick, but more money would help, BeiGene's Oyler says
17 March 2015
Chemistry and now world-class biology are joining hands in China in ways that will have a profound impact on biotechnology startups and established companies. But it is still early days for many and more money from venture capitalists or other funding sources is welcome, said John Oyler, co-founder and CEO of BeiGene and holder of the same title at his previous venture, BioDuro, which was sold to PPD.
17 March 2015
Scientists have identified a new class of drugs that in animal models dramatically slows the aging process by alleviating symptoms of frailty , improving cardiac function and extending a healthy lifespan.
16 March 2015
Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the efficacy and safety results from Clearside’s recently completed six-month Phase 1/2 clinical trial.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024